3,4-dihydroxyphenylacetic acid has been researched along with 4-phenyl-1-(4-phenylbutyl)piperidine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhardwaj, A; Goyagi, T; Hurn, PD; Kirsch, JR; Koehler, RC; Traystman, RJ | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 4-phenyl-1-(4-phenylbutyl)piperidine
Article | Year |
---|---|
Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Gas Analysis; Body Temperature; Brain Chemistry; Brain Ischemia; Chromatography, High Pressure Liquid; Dopamine; Extracellular Space; Haloperidol; Hemodynamics; Homovanillic Acid; Male; Microdialysis; Middle Cerebral Artery; Neostriatum; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, sigma; Reperfusion Injury; Sigma-1 Receptor | 2003 |